UNI-EN 65:Q3 2019 Consolidated Financial report of Sopharma Group.
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 65 | / | 2019 | |||||||
| Date of issue: | 2019-11-29 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Q3 2019 Consolidated Financial report of Sopharma Group. | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Consolidated financial report according to IFRS as at 30 September 2019 Notes to the consolidated financial report as at 30 September 2019 Consolidated management report as at 30 September 2019 Insider information as at 30 September 2019 Additional information as at 30 September 2019 Consolidated financial report according to BFSC standards as at 30 September 2019 Information according to Annex 9 of Ordinance 2 as at 30 September 2019 Declaration by the responsible directors as at 30 September 2019 | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Q3_2019_cons_Financial report_EN.rar 3JR_Q3_2019_cons_Financial report_EN.rar | Q3 2019 Consolidated Financial report of Sopharma Group. | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2019-11-29 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 8.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
